An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-3083|29|4|777-782

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.29, Iss.4, 2015-04, pp. : 777-782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients: Association with B-Cell Markers

By Pyrpasopoulou Athina  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 43-48

Adis International

Access to resources Recommend Favorite

Treatment outcomes in pemphigus vulgaris

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 284-292

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low‐dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single‐centre long‐term review of nine patients

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 59, Iss. 1, 2018-02 ,pp. : e47-e52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 511-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 2, 2018-02 ,pp. : e50-e52

John Wiley & Sons Inc

Access to resources Recommend Favorite